Uptake of Direct Acting Antivirals for Hepatitis C Virus in a New England Medicaid Population, 2014 2017

Tuesday, September 22, 2020
Karen Clements, ScD
Commonwealth Medicine
Parag Kunte, MPH
University of Massachusetts Medical School
Bonnie Greenwood, PharmD, BCPS
Commonwealth Medicine
Carter Pratt, MPH
Laura Sefton , MPP
University of Massachusetts Medical School
Sharina Person, PhD
University of Massachusetts Medical School

This poster by Karen Clements, ScD, assistant professor, Research and Evaluation, discusses factors affecting trends in prescribing direct-acting antivirals for the treatment of hepatitis C (HCV) for a multi-state Medicaid population. Findings reveal that the introduction of new medications and lifting of prior authorization restrictions led to an immediate increase in uptake followed by relatively flat monthly utilization. As a large percentage of the Medicaid HCV population remains untreated, planned provider interviews will provide an understanding of the barriers and facilitators of treatment for HCV. This poster was named best in its category and nominated for best poster at the Academy Health 2020 Annual Research Meeting.

Conference 
Academy Health 2020 Annual Research Meeting